Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2024-08-29 Regulatory Filings
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2024-08-29 English
Interim MD&A - English.pdf
Regulatory Filings
2024-08-29 English
Interim financial statements/report – English.pdf
Regulatory Filings
2024-08-29 English
News release - English.pdf
Regulatory Filings
2024-07-09 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification statement by the CEO regarding the review and fair presentation of the interim financial report and interim MD&A for the period ended March 31, 2024. It is a Form 52-109FV2 certification specific to venture issuers, which is an attestation of the accuracy and completeness of the interim filings. The document does not contain actual financial data or substantive financial analysis but serves as a regulatory officer certification. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3006 characters), and it is clearly a certification letter rather than a full interim report.
2024-07-05 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification statement by the CFO of PreveCeutical Medical Inc. regarding the interim financial report and interim MD&A for the period ended March 31, 2024. It is a FORM 52-109FV2 Venture Issuer Basic Certificate, which is a regulatory certification of the interim filings. The document does not contain actual financial data or substantive financial analysis but rather attests to the accuracy and fair presentation of the interim filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (2964 characters), and it is primarily a certification letter, not the report or announcement of the report publication. Therefore, the correct classification is Regulatory Filings (RNS).
2024-07-05 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.